Clinical Trial Finder

Many patients with cardiomyopathy are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Pulse Reduction On Beta-blocker and Ivabradine Therapy

Conditions:   Dilated Cardiomyopathies, Idiopathic;   Heart Failure, Systolic;   Ventricular Remodeling;   Electrical Remodeling
Interventions:   Drug: Ivabradine;   Drug: Placebo
Sponsors:   University of Colorado, Denver;   American Heart Association;   University of Utah
Recruiting - verified November 2016

Erythropoietin Effect on ischemic_ Reperfusion Injury in Cronary Artery Bypass Graft Surgery

Condition:   Myocardial Ischemic Reperfusion Injury
Interventions:   Drug: normal saline;   Drug: erythropoietin
Sponsors:   Shahid Beheshti University of Medical Sciences;   Pooyesh Darou
Enrolling by invitation - verified December 2016

Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy

Condition:   Transthyretin (TTR) Amyloid Cardiomyopathy
Intervention:   Drug: Tafamidis meglumine
Sponsor:   Pfizer
Recruiting - verified November 2016

Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection

Conditions:   Hypertension;   Hypertrophy
Intervention:   Drug: Hyperpolarized (13) Pyruvate Injection
Sponsor:   Sunnybrook Health Sciences Centre
Recruiting - verified December 2016

Intravenous Administration of Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) in Patients With Recent Onset Anthracycline-Associated Cardiomyopathy

Condition:   Cardiomyopathy
Interventions:   Biological: Human Mesenchymal Stem Cells (hMSCs);   Other: Standard of Care
Sponsor:   M.D. Anderson Cancer Center
Recruiting - verified December 2016

Right Ventricle (RV) Markers of Future Pacing Induced Ventricular Dysfunction - Pilot

Condition:   Sick Sinus Syndrome
Sponsors:   Basildon and Thurrock University Hospitals NHS Foundation Trust;   Anglia Ruskin University
Completed - verified December 2016

Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.

Conditions:   Heart Failure;   Left Ventricular Systolic Dysfunction
Interventions:   Device: ICD;   Device: ILR
Sponsors:   Flinders University;   South Australian Health and Medical Research Institute
Recruiting - verified November 2016

Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism

Conditions:   Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency;   Carnitine Palmitoyltransferase Deficiencies (CPT1, CPT2);   Mitochondrial Trifunctional Protein Deficiency;   Long-chain Hydroxyacyl-CoA Dehydrogenase Deficiency;   Glycogen Storage Disorders;   Pyruvate Carboxylase Deficiency Disease;   ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9, DEFICIENCY of;   Barth Syndrome
Intervention:   Drug: triheptanoin
Sponsors:   University of Pittsburgh;   Ultragenyx Pharmaceutical Inc
Available - verified November 2016

Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy

Condition:   Cardiomyopathy
Interventions:   Device: Sympathetic Nerve Activity;   Behavioral: Mental Stress Test (Color Word Test);   Drug: The Modified Oxford Technique for Baroreflex Sensitivity;   Other: Cold Pressor Test;   Device: Echocardiographic evaluation
Sponsor:   University of Missouri-Columbia
Terminated - verified October 2016

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Conditions:   Transthyretin Mutations;   Transthyretin Amyloidosis
Intervention:   Other: None. Observational Study.
Sponsor:   Pfizer
Recruiting - verified November 2016

Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure

Conditions:   Heart Failure;   Dilated Cardiomyopathy
Intervention:   Drug: clenbuterol
Sponsors:   Francis D. Pagani;   Georgetown University;   Montefiore Medical Center;   Northwestern University;   Ohio State University;   Texas Heart Institute;   University of Minnesota - Clinical and Translational Science Institute;   University of Pennsylvania;   Thoratec Corporation
Terminated - verified November 2016

Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy

Condition:   Dilated Cardiomyopathy
Interventions:   Device: protein A immunoadsorption;   Device: pseudo-immunoadsorption
Sponsors:   University Medicine Greifswald;   Krupp von Bohlen und Halbach-Foundation, Essen, Germany;   ENDI-Foundation, Bad Homburg, Germany;   Bristol-Myers Squibb
Recruiting - verified November 2016

Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy

Condition:   Small Cell Lung Cancer
Intervention:   Drug: Amrubicin
Sponsor:   Celgene Corporation
Completed - verified November 2016